Lege Artis Medicinae

[The role of echocardiography in anticoagulant treatment]

TEMESVÁRI András1

NOVEMBER 30, 1994

Lege Artis Medicinae - 1994;4(01 KLSZ)

[Echocardiography is the method of choice to detect the cardiac source of embolism. Trans thoracic echocardiography is preferred for the diagnosis of left ventricular thrombus. Trans esophageal echocardiography is more sensitive than transthoracic echocardiography in the detection of possible sources of systemic emboli (41-65% versus 14–37%). Left atrial and appendage thrombus, spontaneous echocontrast, patent foramen ovale, atrial septum aneurysm, left atrial myxoma and prosthetic valve thrombus are more frequently demonstrated by transeso phageal echocardiography. Right atilai and ventricular thrombus, embolus in the pulmonary artery, patent foramen ovale and pulmonary hypertension should be examined in pulmonary embolism. ]

AFFILIATIONS

  1. Országos Kardiológiai Intézet, Budapest

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[Introduction]

FENYVESI Tamás

[This LAM supplement was prompted by a very topical issue. Antithrombotic therapy has come to the forefront of the treatment of cardiovascular patients. Prolonged anticoagulant therapy involves mainly the use of coumarin derivatives, and platelet aggregation inhibition involves the extensive use of acetylsalicylic acid. The topicality of this issue can be approached from two angles. First, the incidence of ischaemic heart disease and cerebrovascular disease in the developed world is alarmingly high.]

Lege Artis Medicinae

[Antithrombotic therapy in cardiogenic thromboembolism]

LENGYEL Mária

[All 3 methods of antithrombotic therapy have a role in the primary and secondary prevention of cardiogenic thromboembolism. The most important modality is anticoagulant treatment which is indicated now in the majority of cases of nonvalvular atrial fibrillation. An tiplatelet therapy is of limited value in cardiogenic thromboembolism. The expanded clinical use of both kinds of treatment depends on increased safety and unchanged efficacy which can be achieved by reduced dosage and the combination of the two therapeutic methods. Thrombolytic therapy, until recently, has been limited to the thromboembolic diseases of the right heart. Presently, thrombolysis is being more and more often used in the lifesaving treatment of left sided prosthetic valve thrombosis. ]

Lege Artis Medicinae

[Anticoagulant treatment in cerebrovascular diseases]

NAGY Zoltán

[The practice and indication of anticoagulation in the care of cerebrovascular patients is still controversial. It is hoped that improved diagnostic facilities, the extensive use of imaging techniques, more accurate assessment and monitoring of haemostasis, and the increasing number of multicentre studies will help us to better define the conditions for treatment. The use of anticoagulant therapy may be justified in stroke prevention, mainly to prevent cardioembolisation in cases where the probability of stroke is higher than 5%, and in cerebral venous thrombosis and deep vein thrombosis. The use of anticoagulation in the treatment of progressive ischaemic stroke is still controversial. The experience with heparin (coumarins, warfarin) has been well established, whereas there is currently a lack of data and extensive clinical trials on the use of low molecular weight heparins, heparinoids. ]

Lege Artis Medicinae

[Coumarin therapy]

PÉTERFY Miklós

[Coumarin oral anticoagulants are highly effective antithrombotic agents with relatively low risks of serious bleeding. Clinical uses and applications have evolved over the years. Recent changes include a, lower doses are used to treat most patients with thromboses, b, laboratory monitoring has been standardised thus intensities of anticoagulation are equivalent around the world, C, new indications for treatment have emerged from prospoective controlled clinical trials, for example profilaxis of embolic stroke in patients with chronic nonrheumatic atrial fibrillation. Coumarins inhibit the factors II, VII, IX, X and protein C and S. Traditionally the prothrombin time has been used to monitor the antithrombotic effects of the coumarins. The test is performed by the addition of a thromboplastin to recalcified plasma. The sensitivity of the thromboplastin to coumarin induced reduction in clotting factor activity is variable in the assay. Some thromboplastins are very sensitive, others are insensitive. Consequently, patients can receive different doses of coumarin depending on the thromboplastin used. To address this important clinical problem, the prothrombin time ratio is now modified by a factor (ISI) that reflects the „sensitivity" of the thromboplastin used and the result is termed International Normalised Ratio (INR). The main coumarin adverse effects (hae morrhage, teratogenicity and coumarin skin necroses and some special problems of coumarin therapy (diet, coumarin resistance, drug-drug interactions, the problem of over lapping heparin and coumarin, the problem of interval surgery) are also discussed.]

All articles in the issue

Related contents

Clinical Neuroscience

[Relationship between patent foramen ovale and cryptogenic stroke in a retrospective hospital-based study]

BÖJTI Péter Pál, BARTHA Noémi Eszter, MAY Zsolt, BERECZKI Dániel, FÜLÖP Szilvia, SZAKÁCS ZOLTÁN, SZILÁGYI Géza

[Objective - After routine workup, 23-25% of ischemic strokes etiology remains unknown, i.e. cryptogenic. However, according to international results pathogenic patent foramen ovale (PFO) reveals in 25% of these cases. Aim of our retrospective study to prove the substantial etiological role of PFO-related stroke (PFO-RS) in cryptogenic strokes (CS), and to identify age related differences in stroke etiology. Methods - All new ischemic strokes of 2014-2015 were classified by ASCOD (Atherosclerosis, Small-vessel disease, Cardiac pathology, Other, Dissection) phenotyping. CS was defined when the etiology was unknown. With the help of special ultrasound techniques and RoPE (Risk of Paradoxical Embolism) score the portion of PFO-RS were determined in the examined CS population. Moreover, etiological distribution and differences between age groups (<40, 40-60, >60 years) were described. Results - During the examined period, 8.12% of 985 new ischemic strokes were categorized as CS. 41.38% of examined CS were found to be PFO-related. PFO-RS were considerably more frequent in the younger age groups than in the older age groups. The probability of appearance of PFO-RS were significantly higher in younger age than in case of age independency. Our results verify the substantial etiological role of PFO-RS in CS, and confirm the essential role of contrast enhanced functional transcranial Doppler in the routine diagnostic workup. Age related differences in stroke etiology were found to be statistically significant (p=0.000, df=14), in which small-vessel disease, cardiac pathology, dissection, other pathologies, CS and PFO-RS were contributed significantly. Based on our results, till in young age rare etiologies are typical, while in older age classical etiologies are mainly characteristic.]

Lege Artis Medicinae

[Intraoperative transesophageal echocardiography]

NAGY András, LENGYEL Mária, TEMESVÁRI András

[The authors assessed the value of intraoperative transesophageal echo cardiography in the completion of the preoperative diagnosis and in the evaluation of the surgical result. Examinations were performed in the course of 37 cardiac surgeries. 26 cases were mitral valve procedures or reoperations while 2 cases were aortic valve repairs. These were elective examinations for the purpose of evaluating surgical results. In 4 cases elective examinations were performed to complete the preoperative diagnosis. In 5 cases, intraoperative transesophageal echocardiography was requested by the surgeon during the operation. The intraoperative transesophageal echocardiography included 2D echo, color, pulsed wave and continuous wave Doppler techniques. Intraoperative transesophageal echocardiography was performed on all patients with no complications. On the basis of the structural and haemodynamic information obtained by this procedure, it surgical outcome was assessed and the questions posed by surgeons were answered. In 14 cases, the result of surgery was insufficient. In 12 of these cases, the operation was successfully completed with an altered surgical strategy based on the results of the intraoperative transesophageal echocardiography, and thus early reoperation was prevented. In 2 patients, the surgical procedure could not be completed due to an increased operative risk, despite the insufficient result. Intraoperative transesophageal echocardiography is a safe method to assist in completing the preoperative diagnosis and to evaluate the results of surgery. ]

Lege Artis Medicinae

[Transesophageal and transthoracic echocardiography in aortic dissection]

LENGYEL Mária

[ The severe prognosis of aortic dissection can only be improved by early diagnosis. The role of echocardiography was assessed. Echocardiographic findings were analysed in 32 patients in whom aortic dissection was confirmed by other methods between September 1984 and July 1991. In 19 of them only transthoracic echo (TTE), in 13 patients both TTE and transesophageal echo (TEE) was performed. Control group consisted of 21 patients in whom the clinical suspicion of dissection was ruled out. The DeBakey classification was used. Among 14 acute and 18 chronic cases type I was confirmed in 9, type II in 15 and type III in 8. The sensitivity of clinical suspicion, TTE, TEE and angiography was 34, 72, 92, 94% resp. TEE correctly identified the types, entry and reentry sites, false lumen and left coronary ostium. TTE was valuable in the detection of complications and of etiologic factors of dissection. Hypertension (12) and Marfan's syndrome (7) were the leading etiologic factors. As previously has been reported in the diagnosis of aortic dissection TEE was a safe and reliable technique. It was superior to TTE and was as correct as angiography. The combined use of TTE and TEE is recommended in each case of clinically suspected dissection. The importance of the echocardiographic detection of cardiac complications and etiologic factors is emphasized in the management and prevention.]

Lege Artis Medicinae

[New treatment option for oral anticoagulation in the prevention of cardiogenic stroke - Focus on the RE-LY trial]

SZAPÁRY László

[Atrial fibrillation (AF) represents the most common cause of cardioembolic stroke. The prevalence of AF increases with age and affects 10% of elderly people. AF-related stroke is usually severe and has a high mortality. The risk of stroke can be estimated on the basis of risk factors accompanying AF and age. Patients with one of the highest risk are those with AF and previous TIA or stroke. Efficient prevention is achieved by chronic anticoagulation therapy. In clinical practice, the use of vitamin K antagonists (VKA) has been the only option. The use of these agents is limited for a number of reasons, and clinicians are especially reluctant to use them in elderly patients at high risk of stroke. Consequently, of the patients with AF for whom anticoagulant therapy is indicated, only about 50-60% receives such therapy, and only half of the treated patients achieves target INR values. More than 50 years after the introduction of warfarin, data of trials with the new direct thrombin inhibitor dabigatran have been published in the past few years. In this paper, we review the results of the phase III, international RE-LY trial, published in 2009, which evaluated the preventive efficacy dabigatran etexilate in patients with AF compared with warfarin at a therapeutic dose. On the basis of the results, dabigatran used at a dose of 2×110mg daily provides the same protection as warfarin, whereas at a dose of 2×150mg it provides a signiificantly more efficient protection from AF-associated stroke and systemic embolism. In addition to its excellent preventive effect, dabigatran tretament results in a significant decrease in the risk of intracranial haemorrhages, and of other major haemorrhages. On the basis of the results, dabigatran will probably change the current treatment paradigm in the stroke prevention in patients with AF, and its introduction can substantially increase the number of patients treated efficiently and safely.]

Lege Artis Medicinae

[Antithrombotic therapy in cardiogenic thromboembolism]

LENGYEL Mária

[All 3 methods of antithrombotic therapy have a role in the primary and secondary prevention of cardiogenic thromboembolism. The most important modality is anticoagulant treatment which is indicated now in the majority of cases of nonvalvular atrial fibrillation. An tiplatelet therapy is of limited value in cardiogenic thromboembolism. The expanded clinical use of both kinds of treatment depends on increased safety and unchanged efficacy which can be achieved by reduced dosage and the combination of the two therapeutic methods. Thrombolytic therapy, until recently, has been limited to the thromboembolic diseases of the right heart. Presently, thrombolysis is being more and more often used in the lifesaving treatment of left sided prosthetic valve thrombosis. ]